How is metabolic adaptation measured?
Metabolic adaptation is quantified through tissue-specific readouts of substrate handling, endocrine signalling and transcriptional reprogramming, measured across dietary, surgical and genetic models in mice, quail, cell
Metabolic adaptation is the umbrella term for the coordinated shifts in substrate oxidation, endocrine signalling and gene expression that a tissue makes when nutrient supply, energy demand or hormonal input changes. It is not a single analyte; it is a set of measurable responses, and the literature measures it through four recurring readout classes: circulating metabolite and hormone concentrations, tissue enzyme or transporter abundance, transcriptional and proteomic signatures, and functional outcomes such as glucose tolerance or body-weight trajectory. The formal identifiers attached to a given measurement depend on the molecule being assayed rather than on the concept itself, so a study of hepatic glutamate dehydrogenase (GDH) reports the enzyme and its genetic model, while a study of a mitochondrial peptide reports the open reading frame that encodes it.
The work surveyed here centres on the hepatic and adipose arms of nutrient-sensing and stress-adaptation pathways, including the fibroblast growth factor 21 (FGF21) axis, the REV-ERB nuclear receptor, and mitochondria-derived peptide signalling.
Research Studies
Liver GDH and the animal-versus-plant protein switch
Control mice and Hep-Glud1-/- mice lacking liver GDH were fed animal- or plant-based diets for four days with matched macronutrient spectra. Hepatic GDH was upregulated in control mice on animal protein relative to the plant regimen, and ad libitum-fed control mice on the plant regimen showed lower glycemia than those on animal protein. The authors concluded that a transition to dietary plant-based proteins requires functional liver GDH for proper control of ammonia and energy homeostasis [1].
HLA-G and tumour-intrinsic growth in renal cell carcinoma
In clear cell renal cell carcinoma, elevated HLA-G expression in the TCGA cohort was associated with immunosuppressive programmes and cell populations, and single-cell RNA sequencing placed HLA-G expression in tumour epithelial clusters alongside hypoxia-associated signatures. Integrated transcriptomic, in vitro and in vivo approaches supported a tumour-intrinsic role for HLA-G in growth and survival [2].
Hepatic proteomic recovery in Japanese quail after refeeding
Eighteen 12-week-old male quails (245.20 ± 0.213 g) were assigned to three groups (n = 6): ad libitum control (12.13 MJ/kg), 24 h feed deprivation followed by 6 h refeeding, and a 24 h low metabolizable energy diet (6.30 MJ/kg) followed by 6 h refeeding. Of 854 proteins identified, 515 met the filtering criteria, characterising early liver protein signatures during recovery from nutritional stress [3].
Lactiplantibacillus plantarum WJL, FGF21 and low-protein diet in CKD
Low-protein diets were examined in murine models and in a randomized controlled trial in nondiabetic chronic kidney disease patients, with readouts covering glucose homeostasis, plasma uremic toxins, gut microbiota remodelling and endocrine adaptation. In both settings, the low-protein diet improved glucose tolerance and decreased circulating gut-derived uremic toxins while reducing body weight (−33% in the reported model). The authors framed the probiotic intervention as acting through inhibition of the FGF21 adaptive stress response [4].
Cmpks1 disruption and carotenoid biosynthesis in Cordyceps militaris
Cmpks1, a light-induced gene encoding a reducing type I polyketide synthase, was identified as a regulator of pigment biosynthesis; its transcription was CmWC-1-dependent and upregulated during fruiting body development. CRISPR/Cas9 loss-of-function mutants showed stable albino phenotypes while retaining fruiting body differentiation, and disruption abolished carotenoid biosynthesis and increased sensitivity to high stress [5].
REV-ERB agonism and sorafenib response in liver cancer
Genome-wide RNA-seq in hepatocellular carcinoma identified mitochondrial oxidative phosphorylation and Hmox1 upregulation as features of the model. The REV-ERB agonist SR9009 was reported to potentiate sorafenib efficacy, positioning metabolic vulnerability as a targetable axis in this malignancy [6].
Mitochondria-derived peptides as hepatic metabolic regulators
Mitochondria-derived peptides are encoded by small open reading frames within mitochondrial DNA. Humanin, the first described, acts as a cytoprotective factor against stress-induced apoptosis; MOTS-c regulates metabolic homeostasis and stress adaptation; and SHLP1-6 modulate mitochondrial bioenergetics and insulin sensitivity. In liver, these peptides maintain mitochondrial function and metabolic balance [7].
Probiotic intervention and weight regain in weight cyclers
A registered clinical study is evaluating a probiotic preparation in weight cyclers, on the premise that metabolic adaptations following caloric restriction drive weight regain and that gut microbiota modulation may reduce it by affecting appetite and metabolism [8].
Comparison of measurement readouts across models
| Model | Adaptation stimulus | Primary readout |
|---|---|---|
| Mouse, liver GDH knockout [1] | 4-day plant vs animal protein diet | Hepatic GDH abundance, glycemia |
| Japanese quail [3] | 24 h deprivation or low-energy diet, then 6 h refeeding | Hepatic proteomic signature (854 proteins identified) |
| Murine CKD models and human RCT [4] | Low-protein diet | Glucose tolerance, plasma uremic toxins, microbiota, body weight |
| ccRCC tissue and models [2] | Tumour microenvironment | HLA-G expression, hypoxia-associated programmes |
If you are reading this for personal health reasons
The compounds and interventions described here are laboratory research materials and experimental models, not consumer products, and we do not provide dosing, medical guidance or personal health advice of any kind. Anyone considering a compound or a dietary strategy for themselves should speak to a licensed clinician.
Sources
- [1] Transition to dietary plant-based proteins requires functional liver GDH
- [2] HLA-G as a tumor-intrinsic driver in renal cell carcinoma
- [3] Early hepatic protein responses to dietary restriction-refeeding in Japanese quail
- [4] Lactiplantibacillus plantarum WJL and FGF21 adaptive stress response in CKD
- [5] CRISPR/Cas9 disruption of Cmpks1 in Cordyceps militaris
- [6] REV-ERB agonist SR9009 and sorafenib efficacy in liver cancer
- [7] Mitochondria-derived peptides in liver disease
- [8] Probiotic preparation intervention in weight cyclers